Damien HancoxSpectrumX receives ISO 14001 certification for the manufacture of its HOCl-based productsI am delighted to announce that this week SpectrumX has received International Organisation for Standards (ISO) 14001 certification for the…Feb 20, 2023Feb 20, 2023
Damien HancoxSpectrumX featured in The Care Home Environment magazineInfection prevention is top of mind for healthcare facilities, especially hospitals and care homes, which service vulnerable populations…Feb 14, 2023Feb 14, 2023
Damien HancoxSpectrumX receives approval from HMRC for Enterprise Investment Scheme to provide tax relief for…In the last week, I’m pleased to say we received some welcome news for interested investors that SpectrumX has been approved for Enterprise…Feb 10, 2023Feb 10, 2023
Damien HancoxThe pharmaceutical industry has a few winning cards in the war against the super bugs“The mutability of bacteria, coupled with their ability to pass around and share genetic trumps in a microscopic game of cards, seems to…Jan 20, 2023Jan 20, 2023
Damien HancoxSpectrumX confirms next step in clinical development of respiratory drug candidate SPX-001 after…At the end of last year, I was thrilled to announce that SpectrumX completed a constructive scientific advice meeting on 14 November with…Jan 16, 2023Jan 16, 2023
Damien HancoxThe race is on: will UK life sciences be a winner or an also-ran?Last week, the Financial Times ran an article titled “The UK’s dream of becoming a ‘science superpower’” which delved into whether the UK…Jan 13, 2023Jan 13, 2023
Damien HancoxSpectrumX reaches partnership agreement on human volunteer study for ground-breaking respiratory…The pharmaceutical side of our business focuses on the development of novel drug candidates for respiratory infections. In September, I was…Jan 11, 2023Jan 11, 2023
Damien HancoxSpectrumX to provide full-service infection prevention solution to healthcare facilitiesPoor hand hygiene compliance among healthcare workers is one of the leading sources of transmission of hospital-acquired infections (HAIs)…Jan 9, 2023Jan 9, 2023
Damien HancoxLab data shows Spectricept™ products neutralise C. difficile spores within minutesAt SpectrumX, one of our key areas of focus is developing and manufacturing effective infection prevention products using our…Jan 6, 2023Jan 6, 2023
Damien HancoxCheers to an eventful 2022 for SpectrumX and more to look forward to in 2023Hello, and a very Merry Christmas and a Happy New Year to all as we put a bow on 2022. As I’m sure we all do as the year comes to a close…Dec 21, 2022Dec 21, 2022
